NewVert will now shift to long-term durability testing for Octopus as the company prepares regulatory applications in anticipation of commercial release, NewVert CEO Hagay Drori said.
The Institute of Orthopaedic Research and Biomechanics in Ulm, Germany conducted the biomechanical evaluation.
More Articles on Orthopedic Devices:
DJO Surgical Signs Agreement with University of Utah for Prosthetic Implants
NuVasive Announces $154.4M Revenue for 2Q, Up 16.1%
MEDICREA Sales Increase 32% Over First Half of 2012
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.